Dermatology · Warren, MI
NPI
1205831005
Since 2005
Specialty
Dermatology
Code 207N00000X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
11900 E 12 Mile Rd, Ste 201
Warren, MI, 48093
Phone (586) 574-2800
Groups this clinician bills Medicare through
Medicare paid, 2024
$330K
7,520 services
Medicare patients, 2024
1,029
Average age 75
Drug cost, 2024
$1.4M
2,650 prescriptions
Company payments, 2025
$358K
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David A Altman was code 17003 (destruction skin lesion), 2,289 times for 289 patients. In total David A Altman billed 7,520 services in 67 codes, and Medicare paid $330K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-07-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 2,289 | 289 | $4.95 | $11K |
| 99213 Office E&M - Established | Office | 1,382 | 673 | $64.26 | $89K |
| 17000 Destruction Skin Lesion | Office | 948 | 375 | $42.72 | $41K |
| 99214 Office E&M - Established | Office | 600 | 299 | $88.45 | $53K |
| 11102 Skin Biopsy | Office | 489 | 391 | $66.43 | $32K |
| 88305 Surgical Pathology Examination | Office | 483 | 344 | $54.41 | $26K |
| 99212 Office E&M - Established | Office | 143 | 128 | $42.35 | $6,055 |
| 11103 Skin Biopsy | Office | 124 | 103 | $37.74 | $4,680 |
| 17110 Destruction Skin Lesion | Office | 113 | 88 | $79.38 | $8,970 |
| 99203 Office E&M - New | Office | 88 | 88 | $67.66 | $5,954 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 86 | 47 | $0.74 | $63.72 |
| 96372 Injection Administration | Office | 73 | 33 | $10.06 | $734 |
| 11900 Skin | Office | 60 | 40 | $35.50 | $2,130 |
| 10060 Skin | Office | 44 | 37 | $85.35 | $3,755 |
| J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 36 | 24 | $5.08 | $183 |
By year: 2022 $290K for 6,249 services; 2023 $351K for 7,677 services; 2024 $330K for 7,520 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 483 | 344 | $54.41 | $26K |
| 88304 Surgical Pathology Examination | 18 | 18 | $33.52 | $603 |
| Q0112 All potassium hydroxide (koh) preparations | 12 | 12 | $5.71 | $68.52 |
Medicare prescription drug claims, 2024
In 2024, the drug David A Altman prescribed most often to Medicare patients was Betamethasone Dipropionate, with 254 prescriptions and refills. In total David A Altman wrote 2,650 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Betamethasone Dipropionate Generic | 254 | 261 | 163 | $10K |
| Triamcinolone Acetonide Generic | 212 | 234 | 153 | $1,599 |
| Ketoconazole Generic | 197 | 209 | 124 | $3,885 |
| Mupirocin Generic | 195 | 198 | 156 | $1,251 |
| Hydroxyzine Hcl Generic | 160 | 202 | 77 | $1,390 |
| Ammonium Lactate Generic | 157 | 179 | 108 | $2,285 |
| Metronidazole Generic | 145 | 162 | 81 | $4,228 |
| Fluocinonide Generic | 117 | 127 | 88 | $2,362 |
| Clindamycin Phosphate Generic | 98 | 108 | 68 | $2,065 |
| Hydrocortisone Generic | 91 | 91 | 68 | $364 |
| Doxycycline Hyclate Generic | 82 | 89 | 34 | $2,653 |
| Prednisone Generic | 80 | 80 | 61 | $204 |
| Valacyclovir Valacyclovir Hcl | 62 | 101 | 32 | $1,886 |
| Otezla Apremilast | 61 | 67 | Under 11 | $318K |
| Alclometasone Dipropionate Generic | 52 | 59 | 41 | $1,409 |
Brand drugs: 331 claims; generic drugs: 2,319 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David A Altman $358K ($358K in general payments such as food, travel and fees) from 24 companies. The largest payer was Arcutis Biotherapeutics, Inc. with $60K.
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. ARQT | 45 | $60K |
| Janssen Biotech, Inc. JNJ | 63 | $57K |
| Incyte Corporation INCY | 46 | $53K |
| Lilly USA, LLC LLY | 44 | $36K |
| Genzyme Corporation SNY | 33 | $24K |
| Galderma Laboratories, L.P. GALD.SW | 39 | $22K |
| UCB, Inc. UCB.BR | 31 | $19K |
| Regeneron Healthcare Solutions, Inc. REGN | 32 | $19K |
| Amgen Inc. AMGN | 23 | $18K |
| Sanofi Pasteur Inc. SNY | 1 | $16K |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.